- Argentina
- Australia
- Austria
- Bangladesh
- Belgium
- Botswana
- Brazil
- Bulgaria
- Canada
- Chile
- China
- Colombia
- Cuba
- Czech Republic
- Egypt
- Estonia
- Ethiopia
- Finland
- France
- Germany
- Ghana
- Greece
- Hong Kong
- Hungary
- India
- Indonesia
- Ireland
- Israel
- Italy
- Japan
- Kenya
- Latvia
- Lebanon
- Lithuania
- Malaysia
- Mexico
- Morocco
- Namibia
- Netherlands
- New Zealand
- Nigeria
- Norway
- Pakistan
- Peru
- Philippines
- Poland
- Portugal
- Romania
- Russia
- Saudi Arabia
- Senegal
- Singapore
- Slovakia
- Slovenia
- South Africa
- South Korea
- Spain
- Sweden
- Switzerland
- Taiwan
- Tanzania
- Thailand
- Turkey
- Uganda
- Ukraine
- United Arab Emirates
- United Kingdom
- United States
- Venezuela
- Vietnam
- Zimbabwe
Philippines Business News API
Get the live top business headlines from Philippines with our JSON API.
Get API key for the Philippines Business News APIAPI Demonstration
This example demonstrates the HTTP request to make and the JSON response you will receive when you use the news api to get the top headlines from Philippines.
GET
https://gnews.io/api/v4/top-headlines?country=ph&category=business&apikey=API_KEY
{
"totalArticles": 252460,
"articles": [
{
"id": "23a1ef5c2bab2d34b5e82912e1e62ce1",
"title": "FDA Accepts LEQEMBI® IQLIKTM (lecanemab-irmb) Supplemental Biologics License Application as a Subcutaneous Starting Dose for the Treatment of Early Alzheimer's Disease under Priority Review",
"description": "/PRNewswire/ -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, \"Eisai\") and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge,...",
"content": "If approved, LEQEMBI IQLIK would be the first and only anti-amyloid treatment to offer at-home injection options for initiation and maintenance dosing for this progressive, relentless disease\nFDA action date set for May 24, 2026\nTOKYO and CAMBRIDGE, ... [22748 chars]",
"url": "https://www.prnewswire.com/news-releases/fda-accepts-leqembi-iqliktm-lecanemab-irmb-supplemental-biologics-license-application-as-a-subcutaneous-starting-dose-for-the-treatment-of-early-alzheimers-disease-under-priority-review-302669609.html",
"image": "https://mma.prnewswire.com/media/723010/Eisai_Logo_and_Biogen_Logo.jpg?p=facebook",
"publishedAt": "2026-01-25T23:30:00Z",
"lang": "en",
"source": {
"id": "4e4307a07d2ce1e31acaf932954d3dd9",
"name": "PR Newswire",
"url": "https://www.prnewswire.com"
}
},
{
"id": "5b3c2f7a91325ed64d1fbdc1a270e629",
"title": "Data at 2026 Boswick Burn & Wound Symposium highlight first integrated use of AVITA Medical technologies",
"description": "First surgeon-reported case using RECELL®, PermeaDerm®, and Cohealyx™ together in a single care pathwayNew clinical and tissue-level data on PermeaDerm and Cohealyx highlight wound bed preparation and readiness for closureRECELL analyses show consistent trends in healing, reduced complications, and shorter hospital stays across studies and real-world registry data VALENCIA, Calif., Jan. 25, 2026 (GLOBE NEWSWIRE) -- AVITA Medical®, Inc. (ASX: AVH, NASDAQ: RCEL), a leading therapeutic acute wound care company delivering transformative solutions, today announced data from 19 scientific abstracts, including 14 podium presentations, at the 2026 Boswick Burn & Wound Symposium. The presentations include the first surgeon-reported integrated use of all three AVITA Medical technologies - RECELL, PermeaDerm, and Cohealyx - in individual patient cases, as well as clinical and tissue-level findings from separate studies evaluating PermeaDerm and Cohealyx.",
"content": "First surgeon-reported case using RECELL®, PermeaDerm®, and Cohealyx™ together in a single care pathway\nNew clinical and tissue-level data on PermeaDerm and Cohealyx highlight wound bed preparation and readiness for closure\nGet the latest news\ndelive... [10090 chars]",
"url": "https://www.manilatimes.net/2026/01/26/tmt-newswire/globenewswire/data-at-2026-boswick-burn-wound-symposium-highlight-first-integrated-use-of-avita-medical-technologies/2264900",
"image": "https://www.manilatimes.net/manilatimes/uploads/images/2026/01/26/911959.png",
"publishedAt": "2026-01-25T22:35:42Z",
"lang": "en",
"source": {
"id": "e3ad8bbf7dbe3c3defc56a8393455066",
"name": "The Manila Times",
"url": "https://www.manilatimes.net"
}
},
{
"id": "67a71378caefd74bc050971b87983fb2",
"title": "TUMI Celebrates Grand Opening of First China Flagship Store at Shanghai Centre",
"description": "A Milestone Moment Marked by Notable Guests, Immersive Experiences, and Elevated Design",
"content": "A Milestone Moment Marked by Notable Guests, Immersive Experiences, and Elevated Design\nHONG KONG SAR - Media OutReach Newswire - 5 August 2025 -TUMI, the leading international travel, lifestyle and accessories brand, celebrated the grand opening of ... [5504 chars]",
"url": "https://www.manilatimes.net/2026/01/26/tmt-newswire/media-outreach-newswire/tumi-celebrates-grand-opening-of-first-china-flagship-store-at-shanghai-centre/2264897",
"image": "https://www.manilatimes.net/manilatimes/uploads/images/2026/01/26/911953.jpg",
"publishedAt": "2026-01-25T22:05:43Z",
"lang": "en",
"source": {
"id": "e3ad8bbf7dbe3c3defc56a8393455066",
"name": "manilatimes.net",
"url": "https://www.manilatimes.net"
}
}
]
}